Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Explore various ways to reduce monthly expenses and regain control over your budget. Small changes can lead to big savings!
18,263 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
In May, Marvell Technology delivered more than a beat on sentiment, aided by AI infrastructure demand and a strategic...
NVIDIA's Jensen Huang just signaled a major pivot that could reshape the PC landscape. This article breaks down the i...
Dell Technologies beat on revenue with a strong AI server push, while Super Micro Computer posted healthy growth that...
A legendary investor speculates SpaceX could reach $30 trillion by 2040. This piece breaks down what that would requi...
Investors now have dedicated ETFs to take sides on the Magnificent Seven debate, including concentrated exposure via ...
Western Digital stock has surged on AI storage demand and margin gains. Analysts debate if western digital corporatio...
The U.S. government has imposed export controls on Anthropic’s Fable and Mythos, effectively creating a licensing reg...
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Marques Colston and Nick Edwards unveil the Champion Fund, inviting fans to invest in sports with a $500 entry. The p...
Tokyo police have detained a senior figure tied to the Prince Group in a luxury Osaka hotel raid, tying him to a spra...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...